Colon cancer diagnosis and staging classification based on machine learning and bioinformatics analysis. - Ying Su; Xuecong Tian; Rui Gao; Wenjia Guo; Cheng Chen; Chen Chen 078; Dongfang Jia; Hongtao Li; Xiaoyi Lv (Comput. Biol. Medicine, 2022)

DDA-NG: Fusing Non-negative Matrix Factorization and Graph Tranformer to Enhance Potential Dmg-Disease Associations. - Jie Shi; Ying Su; Xiaoyi Lv; Xuecong Tian (ICCEIC, 2024)

Tensor product graph diffusion based on nonlinear fusion of multi-source information to predict circRNA-disease associations. - Hao Liu; Chen Chen 078; Ying Su; Enguang Zuo; Lijun Wu; Min Li; Xuecong Tian; Chenjie Chang; Zhiyuan Cheng; Xiaoyi Lv; Cheng Chen (Appl. Soft Comput., 2024)

Molecular sharing and molecular-specific representations for multimodal molecular property prediction. - Xuecong Tian; Sizhe Zhang; Ying Su; Wanhua Huang; Yongzheng Zhang; Xuan Ma; Keao Li; Xiaoyi Lv; Chen Chen 078; Cheng Chen (Appl. Soft Comput., 2024)

AIGO-DTI: Predicting Drug-Target Interactions Based on Improved Drug Properties Combined with Adaptive Iterative Algorithms. - Sizhe Zhang; Xuecong Tian; Chen Chen 078; Ying Su; Wanhua Huang; Xiaoyi Lv; Cheng Chen; Hongyi Li (J. Chem. Inf. Model., 2024)

A prospective study: Advances in chaotic characteristics of serum Raman spectroscopy in the field of assisted diagnosis of disease. - Yue Liu; Chen Chen 078; Xuecong Tian; Enguang Zuo; Zhiyuan Cheng; Ying Su; Chenjie Chang; Min Li; Cheng Chen; Xiaoyi Lv (Expert Syst. Appl., 2024)

Disentangled global and local features of multi-source data variational autoencoder: An interpretable model for diagnosing IgAN via multi-source Raman spectral fusion techniques. - Wei Shuai; Xuecong Tian; Enguang Zuo; Xueqin Zhang; Chen Lu; Jin Gu; Chen Chen 078; Xiaoyi Lv; Cheng Chen (Artif. Intell. Medicine, 2025)

GMAMDA: Predicting Metabolite-Disease Associations Based on Adaptive Hardness Negative Sampling and Adaptive Graph Multiple Convolution. - Binglu Hu; Ying Su; Xuecong Tian; Chen Chen; Cheng Chen; Xiaoyi Lv (J. Chem. Inf. Model., 2025)